Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
Jamie D. Feusner - Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial
1 x
$
30.00
View Cart
Checkout
Home
Misdiagnosis of Catatonia (OPEN ACCESS)
“Jamie D. Feusner – Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial” has been added to your cart.
View cart
Misdiagnosis of Catatonia (OPEN ACCESS)
$
0.00
Misdiagnosis of Catatonia (OPEN ACCESS) quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Open Access Articles
,
VOL 50 No. 1 Articles 2020
Tags:
Agastya Nayar
,
benzodiazepines
,
catatonia
,
feras-ali-mustafa
,
lorazepam challenge
,
memantine
,
misdiagnosis
Description
Description
Letter to the Editor
Misdiagnosis of Catatonia
By Feras Ali Mustafa, Agastya Nayar
Related products
P. Murali Doraiswamy, MD: Alzheimer’s Disease and the Glutamate NMDA Receptor
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 49 No. 2, 2019 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 49 No. 1, 2019 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Page load link
Go to Top